Comera Life Sciences Holdings, Inc. (CMRA)

CMRA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020
Cash & Equivalents	0.45	6.51	0.16
Cash & Cash Equivalents	0.45	6.51	0.16
Cash Growth	-93.14%	4088.55%	-
Receivables	0.03	0.22	0.12
Inventory	2.51	0	0.02
Other Current Assets	0.07	0.05	0.02
Total Current Assets	3.06	6.78	0.31
Property, Plant & Equipment	0.57	0.55	0.18
Other Long-Term Assets	0.09	0.08	0.06
Total Long-Term Assets	0.66	0.64	0.24
Total Assets	3.73	7.42	0.55
Accounts Payable	1.46	0.42	0.1
Deferred Revenue	0.14	0.5	0.03
Current Debt	0.65	0.12	0.11
Other Current Liabilities	2.8	0.01	0
Total Current Liabilities	5.06	1.05	0.23
Long-Term Debt	0.12	0.2	0.16
Other Long-Term Liabilities	4.8	20.86	0
Total Long-Term Liabilities	4.92	21.06	0.16
Total Liabilities	9.97	22.1	0.39
Total Debt	0.78	0.32	0.16
Debt Growth	139.91%	101.17%	-
Common Stock	0	0	10.68
Retained Earnings	-34.9	-16.9	-11.45
Comprehensive Income	0	-20.86	0
Shareholders' Equity	-6.25	-14.69	0.15
Total Liabilities and Equity	3.73	7.42	0.55
Net Cash / Debt	-0.33	6.19	-0.01
Net Cash Per Share	-0.03	0.32	-0.00
Working Capital	-2	5.74	0.08
Book Value Per Share	-0.60	-0.77	0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.